Novo Nordisk vs Pfizer: Bidding War for Obesity Drugmaker
Major pharmaceutical battle intensifies as Novo Nordisk challenges Pfizer in high-stakes acquisition race for obesity treatment specialist Metsera, reshaping the weight-loss drug market.
Major pharmaceutical battle intensifies as Novo Nordisk challenges Pfizer in high-stakes acquisition race for obesity treatment specialist Metsera, reshaping the weight-loss drug market.